Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required)

The summary for the Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required): This Funding Opportunity Announcement (FOA) invites a renewal application from UH3 DK118748 supported by RFA-RM-16-019. This FOA will support the continuation and completion of HiLo: A pragmatic trial of higher vs lower serum phosphate targets in patients undergoing hemodialysis. The awardee will continue to enroll and follow hemodialysis patients in the HiLo trial to its completion.

Federal Grant Title:	Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-22-501
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.847
CFDA Descriptions:	Information not provided
Current Application Deadline:	October 19th, 2022
Original Application Deadline:	October 19th, 2022
Posted Date:	June 8th, 2022
Creation Date:	June 8th, 2022
Archive Date:	November 24th, 2022
Total Program Funding:
Maximum Federal Grant Award:	$1,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	June 9th, 2022

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See Full Announcement for additional information on eligibility
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-501.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 -...; • Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common M...; • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinica...; • INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not ...; • INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical...; • Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI); • Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinica...